FDA Inspection
ISORX CYCLOTRON CENTERISORX CYCLOTRON CENTER – FDA Inspection, Mar 13, 2026
Record Details
This FDA Inspection record concerns ISORX CYCLOTRON CENTER, with an inspection on March 13, 2026, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · af840374-ff22-415a-84c2-98e6b3dddedd
Inspection Facts
- Inspection number
- 1307106
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 212.10Personnel not qualified
- 21 CFR 212.20(d)Review of records for errors
- 21 CFR 212.20(e)Written QA procedures established, followed
- 21 CFR 212.40(a)Written procedures for control of components, containers, and closures
- 21 CFR 212.50(a)Written control procedures
- 21 CFR 212.50(b)(5)Variations in component amounts
- 21 CFR 212.50(c)(9)Labeling
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ISORX CYCLOTRON CENTER
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2025 | OAI | Dallas District Office | Generic Drug Evaluation |
Other documents for ISORX CYCLOTRON CENTER
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.